| Eugenio Gerardo Galindo, MD | |
|
5401 N G St Ste 300, Mcallen, TX 78504-4894 | |
| (956) 217-7000 | |
| (956) 628-1960 |
| Full Name | Eugenio Gerardo Galindo |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 40 Years |
| Location | 5401 N G St Ste 300, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174599948 | NPI | - | NPPES |
| 138057813 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | J1667 (Texas) | Primary |
| 174400000X | Specialist | J1667 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcallen Oncology Pa | 2466343223 | 2 |
News Archive
Researchers at the Texas Analog Center of Excellence (TxACE) at UT Dallas are working to develop an affordable electronic nose that can be used in breath analysis for a wide range of health diagnosis.
A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.
NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.
Could SARS-CoV-2 become just a seasonal nuisance in the next decade, causing just coughs and sniffles like a common cold, suggests new research? Scientists at the University of Utah, USA, tried to predict the possible future of the novel coronavirus using mathematical models that use learnings from the current pandemic on changes in human immunity over time.
Broadlane, the leading end-to-end cost-management partner for healthcare providers, announced today that New Hanover Regional Medical Center, in Wilmington, North Carolina, has renewed its supply chain relationship with Broadlane for another five years. New Hanover will continue to access Broadlane's unparalleled national contract portfolio of consumable supplies, equipment, pharmaceuticals and purchased services to help manage approximately $130 million in annual supply spend.
› Verified 4 days ago
| Entity Name | Mcallen Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982711743 PECOS PAC ID: 2466343223 Enrollment ID: O20040324001079 |
News Archive
Researchers at the Texas Analog Center of Excellence (TxACE) at UT Dallas are working to develop an affordable electronic nose that can be used in breath analysis for a wide range of health diagnosis.
A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.
NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.
Could SARS-CoV-2 become just a seasonal nuisance in the next decade, causing just coughs and sniffles like a common cold, suggests new research? Scientists at the University of Utah, USA, tried to predict the possible future of the novel coronavirus using mathematical models that use learnings from the current pandemic on changes in human immunity over time.
Broadlane, the leading end-to-end cost-management partner for healthcare providers, announced today that New Hanover Regional Medical Center, in Wilmington, North Carolina, has renewed its supply chain relationship with Broadlane for another five years. New Hanover will continue to access Broadlane's unparalleled national contract portfolio of consumable supplies, equipment, pharmaceuticals and purchased services to help manage approximately $130 million in annual supply spend.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eugenio Gerardo Galindo, MD Po Box 720878, Mcallen, TX 78504-0878 Ph: (956) 217-7000 | Eugenio Gerardo Galindo, MD 5401 N G St Ste 300, Mcallen, TX 78504-4894 Ph: (956) 217-7000 |
News Archive
Researchers at the Texas Analog Center of Excellence (TxACE) at UT Dallas are working to develop an affordable electronic nose that can be used in breath analysis for a wide range of health diagnosis.
A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.
NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.
Could SARS-CoV-2 become just a seasonal nuisance in the next decade, causing just coughs and sniffles like a common cold, suggests new research? Scientists at the University of Utah, USA, tried to predict the possible future of the novel coronavirus using mathematical models that use learnings from the current pandemic on changes in human immunity over time.
Broadlane, the leading end-to-end cost-management partner for healthcare providers, announced today that New Hanover Regional Medical Center, in Wilmington, North Carolina, has renewed its supply chain relationship with Broadlane for another five years. New Hanover will continue to access Broadlane's unparalleled national contract portfolio of consumable supplies, equipment, pharmaceuticals and purchased services to help manage approximately $130 million in annual supply spend.
› Verified 4 days ago
Dona E Cooper-dockery, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 E Nolana Ave, Ste 12, Mcallen, TX 78504 Phone: 956-686-8802 Fax: 956-686-3083 | |
Jasmine Gowarty, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1901 S Col Rowe Blvd, Mcallen, TX 78503 Phone: 956-687-5150 | |
Dr. Juan Jose Salazar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 E Nolana Ave Ste 2, Mcallen, TX 78504 Phone: 956-687-1177 Fax: 956-687-3290 | |
Dr. Encarnacion Rodriguez, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4300 N Mccoll Rd, Mcallen, TX 78504 Phone: 956-630-1170 | |
Rodrigo Erana, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 Us Expressway 83, Mcallen, TX 78503 Phone: 956-661-9840 Fax: 956-661-9841 | |
Dr. Victoria A Rodriguez-quick, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 501 N Ware Rd, Mcallen, TX 78501 Phone: 956-668-0044 | |
Dr. Numan A Arafat, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 E Ridge Rd, Suite 202, Mcallen, TX 78503 Phone: 956-686-5410 |